Brief Summary
The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.
Brief Title
Pilot Test of a Community-based Buprenorphine Treatment Intervention
Categories
Completion Date
Completion Date Type
Actual
Conditions
Opioid Dependence
Injection Drug Use
Eligibility Criteria
Inclusion Criteria:
* at least 18 years old
* English or Spanish fluency
* ever injected drugs
* not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
* clients of our collaborating community-based organization
* interested in buprenorphine treatment
Exclusion Criteria:
* pregnant
* taking more than 60mg of methadone daily in the previous 30 days
* at least 18 years old
* English or Spanish fluency
* ever injected drugs
* not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
* clients of our collaborating community-based organization
* interested in buprenorphine treatment
Exclusion Criteria:
* pregnant
* taking more than 60mg of methadone daily in the previous 30 days
Inclusion Criteria
Inclusion Criteria:
* at least 18 years old
* English or Spanish fluency
* ever injected drugs
* not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
* clients of our collaborating community-based organization
* interested in buprenorphine treatment
* at least 18 years old
* English or Spanish fluency
* ever injected drugs
* not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
* clients of our collaborating community-based organization
* interested in buprenorphine treatment
Gender
All
Gender Based
false
Keywords
Opioid dependence
Injection drug use
Buprenorphine
Opioid agonist treatment
Access to care
HIV risk behaviors
Opioids
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Minimum Age
18 Years
NCT Id
NCT01761110
Org Class
Other
Org Full Name
Albert Einstein College of Medicine
Org Study Id
2012-381
Overall Status
Completed
Phases
Not Applicable
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
Development of a Community-based Buprenorphine Treatment Intervention
Primary Outcomes
Outcome Description
Medical record information will be extracted to determine initiation of buprenorphine treatment, which will be defined as a visit with a medical provider in which buprenorphine is prescribed.
Outcome Measure
initiation of buprenorphine treatment
Outcome Time Frame
60 days
Secondary Ids
Secondary Id
R34DA031066
Secondary Outcomes
Outcome Description
Opioid use will be determined via self-report using the Addiction Severity Index and via urine specimens (e.g., urine toxicology testing).
Outcome Time Frame
60 days
Outcome Measure
opioid use
Start Date
Status Verified Date
First Post Date
First Post Date Type
Estimated
First Submit Date
First Submit QC Date
Std Ages
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
18
Investigators
Investigator Type
Principal Investigator
Investigator Name
Chinazo Cunningham
Investigator Email
chinazo.cunningham@einsteinmed.org
Investigator Phone